MedPath
NMPA Approval

Abatacept Injection

S20200001

January 8, 2020

Drug Information

阿巴西普注射液

恩瑞舒

注射剂

125mg(0.95mL)/支(预充式注射器)

生物制品

January 8, 2020

January 7, 2025

Company Information

Applicant Company

PO Box 4000, Princeton, NJ 08543, USA

Manufacturing Company

bristol-myers squibb holdings pharma, ltd. liability company

Road 686 Km 2.3, Bo. Tierras Nuevas, Manati, PUERTO RICO, 00674, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿巴西普注射液 - NMPA 批准文号 | MedPath